Pangali Forward P/E Sera Prognostics (SERA)

Sera Prognostics (SERA) specializes in developing diagnostic tests for pregnancy determination. The business relies on an intelligent data processing system, which ensures high scalability and profit growth with minimal costs. This price chart captures the P/E ratio at 0.00. The development of biomarkers to identify complication risks within the US legal framework creates a stable humanitarian foundation for the company's growth.

seraprognostics.com - Rasio kapitalisasi marang bathi mangsa ngarep SERA (periode 04.07.2022 - 10.11.2026)

Ringkesan rincian data analitis seraprognostics.com (SERA)

- rega saiki lan proyeksi nilai saham:

Kutipan saham Sera Prognostics|SERA - Prakiraan konsensus analis

- rincian kapitalisasi pasar:

Kapitalisasi pasar Sera Prognostics Inc.|SERA - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- informasi kapitalisasi buku:

Nilai Akuntansi saben Saham Sera Prognostics|SERA - Total Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku seraprognostics.com|SERA - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Utang marang Ekuitas Sera Prognostics|SERA - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Sera Prognostics, Inc.|SERA - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Sera Prognostics Inc.|SERA - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Sera Prognostics|Likuiditas cepet seraprognostics.com

- rincian asil keuangan lan kelipatan valuasi:

SERA - Bathi pungkasan|Proyeksi bathi mangsa ngarep Sera Prognostics|SERA - Pangali P/E|Prakiraan rega marang bathi Sera Prognostics|SERA - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Sera Prognostics Inc.|SERA - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Sera Prognostics|SERA - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan seraprognostics.com|SERA - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Sera Prognostics

Ringkesan analitik perusahaan:SERA Sera Prognostics

Produk mawa merek Sera Prognostics, Inc.

The uniqueness of Sera Prognostics (SERA) biomarkers ensures stable demand in reproductive medicine and protects its market niche. The trend of the company's forward P/E ratio reflects the current market value of shares relative to expected net income. This multiple measures the extent to which investors are discounting future cash flows. By analyzing this chart, one can identify abnormal liquidity spikes or the risk of asset overvaluation. The current trend demonstrates the market consensus regarding the pace of business expansion.

Pesaing utama

Prakiraan rega marang bathi NTRA (Natera)|Pangali Forward P/E Humacyte Inc (HUMA)